1-4 of 4
Lauriane Clement filliatre, MD
Close
Sort by
Journal Articles

Amahrelis : Adcetris Maintenance after Autologous Stem Cell Transplantation in Hodgkin Lymphoma : A Real Life Study from Sfgmtc and Lysa Groups

Amira Marouf, Anne Ségolène Cottereau, MD, Guillemette Fouquet, MD, Salim Kanoun, MD, Patricia Franchi, MD, Romain Ricci, Michel Meignan, MD, David Sibon, MD PhD, Thomas Gastinne, MD, Cecile Borel, MD, Mohammad Hammoud, MD, Guillaume Sicard, MD, Romane Gille, Doriane Cavalieri, MD, Aspasia Stamatoulas Bastard, MD, Lauriane Clement-Filliatre, MD, Julien Lazarovici, MD, Adrien Chauchet, MD, Luc Mathieu Fornecker, MD PhD, Sandy Amorin, MD, Mathieu Roquet, Nicole Raus, Data Manager, Rene-Olivier Casasnovas, MD, Guillaume Cartron, MD PhD, Hervé Ghesquieres, MD PhD, Pauline Brice, MD, Olivier Hermine, Didier Bouscary, MDPhD, Marie Thérèse Rubio, MD PhD, Jerome Tamburini, MD PhD, Benedicte Deau Fischer
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138666
Published: 2020
Journal Articles

Subcutaneous Daratumumab (DARA SC) Plus Standard-of-Care (SoC) Regimens in Multiple Myeloma (MM) across Lines of Therapy in the Phase 2 Pleiades Study: Initial Results of the Dara SC Plus Carfilzomib/Dexamethasone (D-Kd) Cohort, and Updated Results for the Dara SC Plus Bortezomib/Melphalan/Prednisone (D-VMP) and Dara SC Plus Lenalidomide/Dexamethasone (D-Rd) Cohorts

Philippe Moreau, MD, Ajai Chari, Mathias Haenel, MD, Albert Oriol, Paula Rodriguez-Otero, MD PhD, Helen McCarthy, PhD FRCPath, Kenshi Suzuki, MD PhD, Vania T. M. Hungria, MD PhD, Anna Sureda Balari, MD PhD, Lauriane Clement-Filliatre, MD, Cyrille Hulin, MD, Hila Magen, MD, Shinsuke Iida, MD PhD, Vladimir Maisnar, MD, Lionel Karlin, MD, Luděk Pour, MD, Cyrille Touzeau, Shiyi Yang, Michele Kosh, Maria Delioukina, Christoph Heuck, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–30.
https://doi.org/10.1182/blood-2020-134935
Published: 2020
Journal Articles

Real-Life-Setting Effectiveness of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: The Remix Study

Lauriane Clement-Filliatre, MD, Lotfi Benboubker, MD, Anne-Marie Stoppa, Philippe Rodon, MD, Kamel Laribi, MD, Laure Vincent, Philippe Collet, Valentine Richez, MD, Anne Charvet-Rumpler, Hacene Zerazhi, MD, Cyrille Hulin, MD, Frederic Maloisel, MD PhD, Margaret Macro, Lionel Karlin, MD, Nathalie Texier, Christos Chouaid, Xavier Leleu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-133807
Published: 2020
Journal Articles

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study

Aspasia Stamatoullas, MD, Herv Ghesquieres, Lauriane Clement filliatre, MD, Philippe Quittet, MD, Franck Morschhauser, MD, Vincent Ribrag, MD, Veronique Edeline, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 132.
https://doi.org/10.1182/blood-2019-123925
Published: 2019